Spina bifida and genetic factors related to myo-inositol, glucose, and zinc

Molecular Genetics and Metabolism

Volumn 82, Issue 2, 2004, Pages 154-161

  Groenen, P M W ^a   Klootwijk, R ^a   Schijvenaars, M M V A P ^a   Straatman, H ^a   Mariman, E C M ^b   Franke, B ^a   Steegers Theunissen, R P M ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Gene environment interaction; Glucose; Inositol; ISYNA1; SLC39A4; SLC5A11; Spina bifda; Transmission disequilibrium testing; Zinc

Indexed keywords

GLUCOSE; INOSITOL; ZINC;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SPINA BIFIDA; ZINC BLOOD LEVEL;

ALCOHOL DRINKING; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; INFANT; INOSITOL; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; SPINAL DYSRAPHISM; ZINC;

EID: 2542448177     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.03.007     Document Type: Article

References (34)

1. Den Ouden A.L., Hirasing R.A., Buitendijk S.E., de Jong-van den Berg L.T., de Walle H.E., Cornel M.C. Prevalence, clinical aspects and prognosis of neural tube defects in The Netherlands. Ned. Tijdschr. Geneeskd. 140(42):1996;2092-2095
2. Steegers-Theunissen R.P.M., Smithells R.W., Eskes T.K.A.B. Update of new risk factors and prevention of neural-tube defects. Obstet. Gynecol. Surv. 48:1993;287-293
3. MRC Vitamin Study Research Group, Prevention of neural tube defects: results of the Medical Research Council Vitamin Study, Lancet 338 (1991) 131-137
4. Czeizel A.E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1992;1832-1835
5. Greene N.D., Copp A.J. Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med. 3:1997;60-66
6. Cavalli P., Copp A.J. Inositol and folate resistant neural tube defects. J. Med. Genet. 39:2002;E5
7. P.M.W. Groenen, P.G.M. Peer, R.A. Wevers, D.W. Swinkels, B. Franke, E.C.M. Mariman, R.P.M. Steegers-Theunissen, Maternal myo-inositol, glucose and zinc status is associated with the risk of offspring with spina bifida, Am. J. Obstet. Gynecol. 189 (2003) 1713-1719
8. Warkany J., Petering H.G. Congenital malformations of the central nervous system in rats produced by maternal zinc deficiency. Teratology. 5:1972;319-334
9. Brenton D.P., Jackson M.J., Young A. Two pregnancies in a patient with acrodermatitis enteropathica treated with zinc sulphate. Lancet. 2:1981;500-502
10. Buamah P.K., Russell M., Bates G., Ward A.M., Skillen A.W. Maternal zinc status: a determination of central nervous system malformation. Br. J. Obstet. Gynaecol. 91:1984;788-790
11. Cavdar A.O., Bahceci M., Akar N., Erten J., Bahceci G., Babacan E., Arcasoy A., Yavuz H. Zinc status in pregnancy and the occurrence of anencephaly in Turkey. J. Trace Elem. Electrolytes Health Dis. 2:1988;9-14
12. Shaw G.M., Velie E.M., Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA. 275:1996;1093-1096
13. Kallen K. Maternal smoking, body mass index, and neural tube defects. Am. J. Epidemiol. 147:1998;1103-1111
14. Hendricks K.A., Nuno O.M., Suarez L., Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 12:2001;630-635
15. Smith S.M. Alcohol-induced cell death in the embryo. Alcohol Health Res. World. 21:1997;287-295
16. Reece E.A., Khandelwal M., Wu Y.K., Borenstein M. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am. J. Obstet. Gynecol. 176:1997;536-539
17. Myrianthopoulos N.C., Melnick M. Studies in neural tube defects. I. Epidemiologic and etiologic aspects. Am. J. Med. Genet. 26:1987;783-796
18. Cogram P., Hynes A., Dunlevy L.P., Greene N.D., Copp A.J. Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol. Hum. Mol. Genet. 13:2004;7-14
19. Scalera V., Natuzzi D., Prezioso G. Myo-inositol transport in rat intestinal brush border membrane vesicles, and its inhibition by D-glucose. Biochim. Biophys. Acta. 1062:1991;187-192
20. +/glucose cotransporter. Acta Physiol. Scand. Suppl. 643:1998;257-264
21. Uldry M., Ibberson M., Horisberger J.D., Chatton J.Y., Riederer B.M., Thorens B. Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. EMBO J. 20:2001;4467-4477
22. +/myo-inositol cotransporter. J. Biol. Chem. 277:2002;35219-35224
23. Roll P., Massacrier A., Pereira S., Robaglia-Schlupp A., Cau P., Szepetowski P. New human sodium/glucose cotransporter gene (KST1): identification, characterization, and mutation analysis in ICCA (infantile convulsions and choreoathetosis) and BFIC (benign familial infantile convulsions) families. Gene. 285:2002;141-148
24. Majumder A.L., Johnson M.D., Henry S.A. 1L-myo-inositol-1-phosphate synthase. Biochim. Biophys. Acta. 1348:1997;245-256
25. Wang K., Zhou B., Kuo Y.M., Zemansky J., Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet. 71:2002;66-73
26. Kury S., Dreno B., Bezieau S., Giraudet S., Kharfi M., Kamoun R., Moisan J.P. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat. Genet. 31:2002;239-240
27. Lee D.K., Geiser J., Dufner-Beattie J., Andrews G.K. Pancreatic metallothionein-I may play a role in zinc homeostasis during maternal dietary zinc deficiency in mice. J. Nutr. 133:2003;45-50
28. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215
29. Richards B., Skoletsky J., Shuber A.P., Balfour R., Stern R.C., Dorkin H.L., Parad R.B., Witt D., Klinger K.W. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum. Mol. Genet. 2:1993;159-163
30. Jansen G., Muskiet F.A., Schierbeek H., Berger R., van der Slik W. Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin. Chim. Acta. 157:1986;277-293
31. Groenen P.M.W., Merkus H.M.W.M., Sweep F.C., Wevers R.A., Janssen F.S.M., Steegers-Theunissen R.P.M. Kinetics of myo-inositol loading in women of reproductive age. Ann. Clin. Biochem. 40:2003;79-85
32. Haga H., Yamada R., Ohnishi Y., Nakamura Y., Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190, 562 genetic variations in the human genome. Single-nucleotide polymorphism. J. Hum. Genet. 47:2002;605-610
33. Beaty T.H., Hetmanski J.B., Zeiger J.S., Fan Y.T., Liang K.Y., VanderKolk C.A., McIntosh I. Testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet. Epidemiol. 22:2002;1-11
34. +/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J. Biol. Chem. 278:2003;18297-18302